News|Podcasts|January 30, 2025

Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D

Name: Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
Uploaded: 2025-01-31T01:52:15.987Z
Duration: 12 min 42 s
Description: Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D

Author(s)Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES

In this episode, hosts discuss the approval of semaglutide (Ozempic) for reducing the progression of kidney disease in type 2 diabetes.

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!